Cannabis Extract Eases Chronic Back Pain and Improves Quality of Life in Major Clinical Trial

Cannabis extract eases chronic back pain and improves quality of life in major clinical trial

A phase 3 trial in Nature Medicine found that a full-spectrum Cannabis sativa extract (VER-01) significantly reduced chronic low back pain and improved sleep and function compared with placebo. The extract was safe, well-tolerated, and showed no signs of abuse or dependence, with benefits maintained over long-term treatment.

Data backs Vertanical's cannabis therapy for back pain

A phase 3 trial of Vertanical's cannabis extract in back pain has been published, and the results bode well for marketing applications under review.

Cannabis-based drug shows promise for chronic pain in study

Chronic pain affects millions of people worldwide. The often-debilitating condition is typically treated with over-the-counter pain relievers or opioid medications. However, both of these mainstream medicines have risks—some of which have led to severe public health crises. Anecdotally, cannabis has been found to reduce pain for many patients. Now, one pharmaceutical maker is on the verge of introducing a new cannabis-based drug to the market th…

Cannabis Extract Eases Chronic Low Back Pain, Improves Sleep, Mobility

A cannabis extract appears to provide sustained relief from chronic low back pain without signs of addiction or withdrawal, phase 3 data show.

Vertanical unpacks Phase 3 success for cannabis-based painkiller

Vertanical has shared positive results from its only asset in a late-stage trial of 820 people with chronic lower back pain as it awaits the outcome of a review in certain European countries. On Wednesday ...

Full Spectrum Cannabis Extract With Just 2.5mg THC Eases Chronic Lower Back Pain In Landmark Clinical Trial

A landmark phase 3 trial shows the cannabis extract VER-01 significantly reduces chronic lower back pain, improving sleep and quality of life without serious side effects. Discover what this means for medical cannabis, low-dose THC, and future pain treatments.